Nitin Jain

The University of Texas MD Anderson Cancer Center

Also affiliated with Parul University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 69 papers. Top paper: “10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial”.

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30210-6

N/A

6.4DataRank · unranked

334 citations

Abhishek Maiti, Caitlin R. Rausch, Naveen Pemmaraju, Kiran Naqvi, Naval Daver +34 more

Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial

The Lancet Haematology(2021)10.1016/s2352-3026(21)00192-7

N/A

5.0DataRank · unranked

178 citations

Patrick K. Reville, Gautam Borthakur, Musa Yılmaz, Steven M. Kornblau, Yesid Alvarado +13 more

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017

American Journal of Hematology(2021)10.1002/ajh.26156

N/A

3.3DataRank · unranked

131 citations

Elias Jabbour, Nicholas J. Short, Nitin Jain, Farhad Ravandi, Ching‐Hon Pui +2 more

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2020003717

N/A

3.2DataRank · unranked

82 citations

Courtney D. DiNardo, Sa A. Wang, Jeffrey L. Jorgensen, Tapan M. Kadia, Naval Daver +28 more

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia

Blood Advances(2020)10.1182/bloodadvances.2019000767

N/A

2.9DataRank · unranked

56 citations

Wendy Stock, Amer M. Zeidan, Ehab Atallah, James McCloskey, Leonard T. Heffner +11 more

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood(2021)10.1182/blood.2021013290

N/A

2.6DataRank · unranked

87 citations

Pinaki P. Banerjee, Denái R. Milton, Xianli Jiang, Christina Ganesh, Sajad Khazal +24 more

Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia

American Journal of Hematology(2021)10.1002/ajh.26238

N/A

1.8DataRank · unranked

55 citations

Abhishek Maiti, Farhad Ravandi, Marina Konopleva, Naval Daver, Tapan M. Kadia +8 more

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Nature Medicine(2023)10.1038/s41591-022-02113-6

N/A

1.7DataRank · unranked

83 citations

Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch, Sameer A. Parikh +49 more

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells

Haematologica(2023)10.3324/haematol.2022.281915

N/A

1.6DataRank · unranked

71 citations

Lina Han, Cassandra L. Ramage, Zhe Wang, Connie C. Weng, Lei Yang +15 more

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01476-8

N/A

1.3DataRank · unranked

51 citations

Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo +22 more

Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study

American Journal of Hematology(2021)10.1002/ajh.26281

N/A

0.952DataRank · unranked

32 citations

Keyur P. Patel, Nitin Jain, Dzifa Y. Duose, Rajyalakshmi Luthra, Nicholas J. Short +8 more

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia

Blood Advances(2024)10.1182/bloodadvances.2023012231

N/A

0.940DataRank · unranked

34 citations

Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Nasr, Fadi Haddad +18 more

Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

Haematologica(2020)10.3324/haematol.2020.252569

N/A

0.776DataRank · unranked

176 citations

Caitlin R. Rausch, Jörge E. Cortes, Naveen Pemmaraju, Naval Daver, Farhad Ravandi +30 more

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia

Blood Cancer Journal(2021)10.1038/s41408-021-00410-w

N/A

0.728DataRank · unranked

127 citations

Courtney D. DiNardo, Naval Daver, Caitlin R. Rausch, Farhad Ravandi, Tapan M. Kadia +20 more

Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality

American Journal of Hematology(2020)10.1002/ajh.26061

N/A

0.697DataRank · unranked

103 citations

Wei Qiao, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Elias Jabbour +26 more

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Cancer Cell(2023)10.1016/j.ccell.2023.08.013

N/A

0.646DataRank · unranked

73 citations

Camilla K. Lemvigh, Stephanie L. Deng, Nathan Dangle, Neil Ruthen, Binyamin A. Knisbacher +30 more

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Leukemia Research(2022)10.1016/j.leukres.2022.106928

N/A

0.644DataRank · unranked

20 citations

Nathaniel R. Wilson, Jayastu Senapati, Minas P. Economides, Monica L. Guzman, Sattva S. Neelapu +12 more

The cure of leukemia through the optimist's prism

Cancer(2021)10.1002/cncr.33933

N/A

0.633DataRank · unranked

67 citations

Nitin Jain, Guillermo Garcia‐Manero, Mary Alma Welch, Farhad Ravandi, William G. Wierda +2 more

Chronic lymphocytic leukaemia

The Lancet(2024)10.1016/s0140-6736(24)00595-6

N/A

0.626DataRank · unranked

64 citations

William G Wierda, Susan O'Brien, Nitin Jain

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Leukemia(2020)10.1038/s41375-020-0778-0

N/A

0.596DataRank · unranked

52 citations

Srđan Verstovšek, Jörge E. Cortes, Susan Tse, Yvonne Gasior, Nitin Jain +19 more

Phase 2 study of lenalidomide maintenance for patients with high‐risk acute myeloid leukemia in remission

Cancer(2021)10.1002/cncr.33409

N/A

0.547DataRank · unranked

10 citations

Hagop M. Kantarjian, Farhad Ravandi, Naval Daver, Xuemei Wang, Elias Jabbour +16 more

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia

Cancer Cell(2024)10.1016/j.ccell.2024.03.003

N/A

0.542DataRank · unranked

36 citations

Yizhen Li, Jingliao Zhang, Lei Yan, Huanbin Zhao, Liang Ding +21 more

Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019

Cancer(2023)10.1002/cncr.35038

N/A

0.529DataRank · unranked

33 citations

Fadi Haddad, Nicholas J. Short, Nitin Jain, Ghayas C. Issa, Elias Jabbour +2 more

Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1388

N/A

0.515DataRank · unranked

30 citations

Clark R. Andersen, Branko Cuglievan, David McCall, Philip J. Lupo, Susan K. Parsons +7 more

BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma

Leukemia(2021)10.1038/s41375-021-01181-w

N/A

0.510DataRank · unranked

29 citations

Christopher P. Mill, Dimuthu Perera, Christine Birdwell, Qing Deng, Haopeng Yang +13 more

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia

Haematologica(2021)10.3324/haematol.2021.278697

N/A

0.489DataRank · unranked

25 citations

Joseph P. Loftus, Élodie Lainey, Aurélie Caye‐Eude, Morgane Pondrom, David A. Hottman +9 more

Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1429

N/A

0.489DataRank · unranked

25 citations

Warren Fiskus, Naval Daver, Nathaniel R. Wilson, Farhad Ravandi, Guillermo Garcia‐Manero +19 more

Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.12.016

N/A

0.483DataRank · unranked

24 citations

Elias Jabbour, Trevor Jamison, Shilpa Paul, Branko Cuglievan, David McCall +11 more

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

Journal of Hematology & Oncology(2025)10.1186/s13045-025-01709-y

N/A

0.471DataRank · unranked

17 citations

Hagop Kantarjian, Ken Furudate, Nitin Jain, Farhad Ravandi, Omer Karrar +8 more

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era

American Journal of Hematology(2023)10.1002/ajh.27037

N/A

0.457DataRank · unranked

20 citations

Koji Sasaki, Aram Bidikian, Ghayas C. Issa, Tapan M. Kadia, Nitin Jain +11 more

Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2024)10.1200/jco.24.00500

N/A

0.442DataRank · unranked

18 citations

Zhenhua Li, Yoshihiro Gocho, Wenjian Yang, Kristine R. Crews, Shawn H.R. Lee +21 more

Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study

Haematologica(2024)10.3324/haematol.2023.284078

N/A

0.416DataRank · unranked

15 citations

Lucia Masárová, Naveen Pemmaraju, Sharon Bledsoe, Naval Daver, Elias Jabbour +19 more

TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis

American Journal of Hematology(2022)10.1002/ajh.26595

N/A

0.406DataRank · unranked

14 citations

Raamis Khwaja, Rashmi Kanagal‐Shamanna, Guilin Tang, Jan A. Burger, Philip A. Thompson +10 more

Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia

Leukemia(2023)10.1038/s41375-023-01900-5

N/A

0.396DataRank · unranked

13 citations

John C. Panetta, Jianzhong Hu, Lie Li, Yoshihiro Gocho, Guoqing Du +10 more

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia

Blood Cancer Journal(2024)10.1038/s41408-024-01142-3

N/A

0.385DataRank · unranked

12 citations

Priyanka Khare, Priyanka Banerjee, Cristina Ivan, Sarah Schneider, Federica Barbaglio +20 more

Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

Nature Genetics(2025)10.1038/s41588-025-02235-w

N/A

0.385DataRank · unranked

12 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +39 more

Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many Options

American Society of Clinical Oncology Educational Book(2018)10.1200/edbk_200691

N/A

0.373DataRank · unranked

11 citations

Philip Thompson, Alessandra Ferrajoli, Chadi Nabhan, Anthony R. Mato, Susan O’Brien +1 more

Inotuzumab ozogamicin (INO) plus bosutinib (BOS) in R/R PH+ ALL or CML in lymphoid blast phase (CML LBP).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7512

N/A

0.360DataRank · unranked

10 citations

Abhishek Maiti, Farhad Ravandi, Marina Konopleva, Yesid Alvarado, Tapan M. Kadia +14 more

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models

Blood Advances(2024)10.1182/bloodadvances.2024013423

N/A

0.360DataRank · unranked

10 citations

Yizhen Li, Natalia Baran, Yang Xu, Sanaz Ghotbaldini, Qi Zhang Tatarata +11 more

A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.05.013

N/A

0.344DataRank · unranked

8 citations

Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Naveen Pemmaraju, Koichi Takahashi +4 more

A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.020

N/A

0.312DataRank · unranked

7 citations

Tamer Othman, Rima M. Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty, Celina Ledesma +18 more

The Shifting Paradigm in Chronic Lymphocytic Leukemia

The Cancer Journal(2019)10.1097/ppo.0000000000000417

N/A

0.269DataRank · unranked

5 citations

Susan O'Brien, Nitin Jain

Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial

American Journal of Hematology(2024)10.1002/ajh.27254

N/A

0.269DataRank · unranked

5 citations

Kamal Alzahrani, Hagop M. Kantarjian, Denái R. Milton, Alison Gulbis, Koji Sasaki +18 more

A double-blind, placebo-controlled, multi-crossover trial of treatment with a chemokine antagonist for knee osteoarthritis pain

Pain(2026)10.1097/j.pain.0000000000003904

N/A

0.208DataRank · unranked

3 citations

Thaddeus Tarpey, Michael Ashburn, Caitlin Baer, Allison Campbell, Robert H. Dworkin +24 more

Risk of early death after acute leukemia diagnosis among adolescents and young adults

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf065

N/A

0.165DataRank · unranked

2 citations

Clark R. Andersen, Vidya Puthenpura, Nicholas J. Short, Kelly W. Merriman, Mahesh Swaminathan +14 more

Artificial Intelligence Assessment of Chest Radiographs for COVID-19

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.11.013

N/A

0.165DataRank · unranked

2 citations

Guillermo Garcia‐Manero, Masayuki Nigo, Elias Jabbour, Farhad Ravandi, William G. Wierda +14 more

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

medRxiv(2023)10.1101/2023.12.06.23299616

N/A

0.132DataRank · unranked

1 citations

Nicholas J. Short, Hagop M. Kantarjian, Ti‐Cheng Chang, Pankaj S. Ghate, Chunxu Qu +17 more

Safety and Efficacy of G-CSF with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Subgroup Analysis of the Phase II Trial of Venetoclax in Combination with Cladribine, Idarubicin, and Cytarabine

Blood(2024)10.1182/blood-2024-203938

N/A

0.104DataRank · unranked

1 citations

Hagop M. Kantarjian, Musa Yılmaz, Naval Daver, Gautam Borthakur, Courtney D. DiNardo +15 more

Ibrutinib, Fludarabine, Cyclophosphamide and Obinutuzumab (iFCG) for Firstline Treatment of Patients with CLL with Mutated IGHV and without Del(17p)/ TP53 Mutation: Six-Year Follow-up Analyses

Blood(2023)10.1182/blood-2023-188084

N/A

0.104DataRank · unranked

1 citations

Philip A. Thompson, Akhil Jain, Jan A. Burger, Alessandra Ferrajoli, Jayastu Senapati +27 more

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial

Cancer(2025)10.1002/cncr.35840

N/A

0.104DataRank · unranked

1 citations

Hagop M. Kantarjian, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Elias Jabbour +13 more

Single-Cell Proteogenomics Analysis of AML Samples Treated with Decitabine and Venetoclax Reveals Divergent Treatment Escape Mechanisms

Blood(2023)10.1182/blood-2023-190400

N/A

0.104DataRank · unranked

1 citations

Zongrui Li, Abhishek Maiti, Tomoyuki Tanaka, Hidetaka Uryu, Ken Furudate +21 more

Outcomes of Adult Patients with Newly Diagnosed IDH-Mutated Acute Myeloid Leukemia Receiving Intensive Chemotherapy Plus Venetoclax

Blood(2024)10.1182/blood-2024-207413

N/A

0.104DataRank · unranked

1 citations

Jennifer Marvin‐Peek, Marina Konopleva, Gautam Borthakur, Naval Daver, Hussein A. Abbas +21 more

Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton’s tyrosine kinase expression levels

Blood Cancer Journal(2024)10.1038/s41408-024-01196-3

N/A

0DataRank · unranked

1 citations

Ganiraju C. Manyam, Nitin Jain, Cristina Ivan, Betty Lamothe, Mary Ayres +4 more

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells

Oncotarget(2021)10.18632/oncotarget.27884

N/A

0DataRank · unranked

11 citations

David Harris, Ping Li, Zhiming Liu, Preetesh Jain, Taghi Manshouri +10 more

BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia

Blood Advances(2023)10.1182/bloodadvances.2022007728

N/A

0DataRank · unranked

14 citations

Karanpreet Singh Bhatia, Aarthi N. Mahesh, Shazwina Rosli, Jameelah S. Mohamed, Wei‐Ying Jen +8 more

Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL

Leukemia(2023)10.1038/s41375-023-02010-y

N/A

0DataRank · unranked

10 citations

Chunhua Shi, Guojun Yang, Jason Allen, Qing Shi, Amin Al-Shami +15 more

Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Blood(2023)10.1182/blood-2023-182568

N/A

0DataRank · unranked

1 citations

James D’Olimpio, Andew gillis-Smith, Seung‐Tae Lee, Nirav N. Shah, Javier Pinilla‐Ibarz +9 more

CLL Cell-Derived Exosomes Impair Immune Function and Normal Hematopoiesis in CLL

Blood(2023)10.1182/blood-2023-190712

N/A

0DataRank · unranked

1 citations

David Harris, Uri Rozovski, Ping Li, Zhiming Liu, Taghi Manshouri +15 more

MS-553 Therapy Inhibits BCR Signaling and Increases Survival Dependence on BCL-2 in BTK-Inhibitor Resistant CLL

Blood(2023)10.1182/blood-2023-189378

N/A

0DataRank · unranked

1 citations

John R. Sanchez, Chaomei Liu, Bailey Slawin, Nitin Jain, William G. Wierda +6 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Validation of the Prognostic Risk Signatures for Older Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax

Blood(2023)10.1182/blood-2023-182841

N/A

0DataRank · unranked

0 citations

Alexandre Bazinet, Courtney D. DiNardo, Gautam Borthakur, Nicholas J. Short, Elias Jabbour +12 more

Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion and/or TP53 mutations

Blood(2021)10.1182/blood.2021012315

N/A

0DataRank · unranked

24 citations

Ekaterina Kim, William G. Wierda, Alessandra Ferrajoli, Nitin Jain, Philip A. Thompson +4 more

Phase II study of lower-intensity frontline therapy for newly diagnosed patients with AML who are unfit or otherwise not eligible for frontline clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19028

N/A

0DataRank · unranked

0 citations

Elias Jabbour, Naveen Pemmaraju, Guillermo Montalban‐Bravo, Kelly S. Chien, Naval Daver +12 more

Treatment in Clinical Trials Could Potentially Overcome the Disparity in Outcomes of Patients with Acute Myeloid Leukemia from Disadvantaged Neighborhoods

Blood(2024)10.1182/blood-2024-210779

N/A

0DataRank · unranked

0 citations

Hussein A. Abbas, Guillermo Garcia‐Manero, Naval Daver, Tapan M. Kadia, Courtney D. DiNardo +19 more

Clonal Origin of Therapy-Related Myeloid Neoplasms after Autologous Stem Cell Transplant

Blood(2024)10.1182/blood-2024-208106

N/A

0DataRank · unranked

0 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +35 more

Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.03.010

N/A

0DataRank · unranked

0 citations

Elias Jabbour, Álex Bataller, Koji Sasaki, Guilin Tang, Sanam Loghavi +7 more

SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Can Be Treated with Chemotherapy-Free Regimens without Transplant

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.06.019

N/A

0DataRank · unranked

0 citations

Hagop M. Kantarjian, Jayastu Senapati, Nitin Jain, Nicholas J. Short, Elias Jabbour +1 more

Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy‐Based Regimens

American Journal of Hematology(2025)10.1002/ajh.70048

N/A

0DataRank · unranked

0 citations

Elias Jabbour, Nicholas J. Short, Nitin Jain, Ghayas C. Issa, Himachandana Atluri +9 more